KKRC
TMO icon

Kohlberg Kravis Roberts & Co’s Thermo Fisher Scientific TMO Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-58,139
Closed -$8.59M – 59
2016
Q2 		$8.59M Buy
+58,139
New +$8.58M 0.09% 32
2015
Q4 		– Sell
-20,473
Closed -$2.5M – 71
2015
Q3 		$2.5M Buy
+20,473
New +$2.67M 0.03% 56

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's TMO Position: Q3 2016 in Review

Kohlberg Kravis Roberts & Co sold out of Thermo Fisher Scientific (TMO) in Q3 2016, closing a stake of 58,139 shares — an estimated $8.59M sold.

Kohlberg Kravis Roberts & Co first reported a position in TMO in Q3 2015 and held it in 2 quarters. The position peaked at $8.59M in Q2 2016. 1,044 funds tracked by Wall St. Rank hold TMO as of Q3 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining Thermo Fisher Scientific position as of Q3 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 58,139 Thermo Fisher Scientific shares in Q3 2016, an estimated $8.59M.
  • Kohlberg Kravis Roberts & Co first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 2 quarters.
  • Kohlberg Kravis Roberts & Co's Thermo Fisher Scientific position peaked at $8.59M in Q2 2016.
  • 1,044 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2016, filed 14 Nov 2016.